Richard A Moravec
- Co-authors
- Terry RissAndrew L. NilesSarah DuellmanHélène A BeninkTracy J WorzellaLisa MinorWilliam J. DailyMartha A. O’Brien
- Topics
- Computational Drug Discovery Methods (5 papers)Cell death mechanisms and regulation (4 papers)3D Printing in Biomedical Research (4 papers)
- Partner nations
- United StatesCzechia
In The Last Decade
Richard A Moravec
21 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 659
- Biomedical Engineering 205
- Oncology 161
- Organic Chemistry 129
- Immunology 129
Countries citing papers authored by Richard A Moravec
This map shows the geographic impact of Richard A Moravec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A Moravec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A Moravec more than expected).
Fields of papers citing papers by Richard A Moravec
This network shows the impact of papers produced by Richard A Moravec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A Moravec. The network helps show where Richard A Moravec may publish in the future.
Co-authorship network of co-authors of Richard A Moravec
This figure shows the co-authorship network connecting the top 25 collaborators of Richard A Moravec. A scholar is included among the top collaborators of Richard A Moravec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A Moravec. Richard A Moravec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 41 | |
| 3 | Cell Viability Assaysbreakdown → | 349 |
| 4 | 63 | |
| 5 | 76 | |
| 6 | 54 | |
| 7 | 113 | |
| 8 | 104 | |
| 9 | 10 | |
| 10 | 24 | |
| 11 | 12 | |
| 12 | 129 | |
| 13 | MULTITOX-FLUOR MULTIPLEX CYTOTOXICITY ASSAY TECHNOLOGY | 6 |
| 14 | 103 | |
| 15 | 268 | |
| 16 | Apoptosis Marker Assays for HTS | 2 |
| 17 | CASPASE-GLO™ 3/7 ASSAY: USE FEWER CELLS AND SPEND LESS TIME WITH THIS HOMOGENEOUS ASSAY | 4 |
| 18 | CELLTITER-GLO™ LUMINESCENT CELL VIABILITY ASSAY: A SENSITIVE AND RAPID METHOD FOR DETERMINING CELL VIABILITY | 32 |
| 19 | 51 | |
| 20 | The role of antioxidants in skin immune reactions: The use of flow cytometry to determine alterations in la-positive epidermal cells in allergic contact dermatitis | 3 |
About Richard A Moravec
Richard A Moravec is a scholar working on Biophysics, Small Animals and Computational Theory and Mathematics, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Cell death mechanisms and regulation (4 papers) and 3D Printing in Biomedical Research (4 papers). The work is most often cited by research in Biophysics (73 citations), Molecular Biology (659 citations) and Toxicology (28 citations). Richard A Moravec has collaborated with scholars based in United States and Czechia. Frequent co-authors include Terry Riss, Andrew L. Niles, Sarah Duellman, Hélène A Benink, Tracy J Worzella, Lisa Minor, William J. Daily, Martha A. O’Brien, Robert F. Bulleit and Dieter H. Klaubert. Their work appears in journals such as Analytical Biochemistry, Journal of Immunological Methods and Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.